Search for: "In re: Zyprexa Products Liability Litigation" Results 61 - 76 of 76
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Sep 2010, 8:21 am by Steve McConnell
” In re Zyprexa Products Liability Litigation, 671 F. [read post]
20 Mar 2009, 2:05 am
Implantable Defibrillators Products Liability Litigation, 2007 WL 2023569, at *2 (D. [read post]
19 Aug 2009, 7:20 am
 Eli Lilly had secrecy orders on over 8,000 settlements regarding harmful side-effects of the drug Zyprexa. [read post]
5 Mar 2015, 5:52 am
  As far as we can tell it has not yet prevailed in any product liability action. [read post]
7 May 2012, 5:00 am by Bexis
Sherwood Medical Industries, 836 F.2d 296, 302-303 (7th Cir. 1987); In re Zyprexa Products Liability Litigation v. [read post]
30 Aug 2012, 1:08 pm by Bexis
 Hogan was particularly notable because it involved a Rhode Island plaintiff, and there’s just not that much Rhode Island law on anything.Our prior Hogan-related posts:First, the defendant lost a summary judgment motion in the MDL, In re Aredia & Zometa Products Liability Litigation, 2009 WL 2513555 (M.D. [read post]
28 Jun 2010, 3:50 am by Steve McConnell
The Commonwealth relied on In re Zyprexa Products Liability Litigation, 671 F Supp 2d 397 (EDNY 2009). [read post]
15 Apr 2011, 6:02 am by Bexis
Aren’t there a bunch of plaintiffs out there suing Eli Lilly because its anti-schizophrenia drug, Zyprexa supposedly causes diabetes – at least in obese people who would probably contract the disease anyway? [read post]
29 Oct 2008, 12:00 pm
"They want it to appear as if, after Levine, it's lights out on prescription drug product liability litigation generally.While we might also say, "from their lips to God's ears," unfortunately, t'aint so.We wish it were that simple - that stark - but like just about anything in the law it's not cut and dried. [read post]
21 Jun 2011, 5:00 am by Bexis
”  See In re Zyprexa Products Liability Litigation, 671 F. [read post]
23 Oct 2011, 9:06 am by Schachtman
  Later in the chapter, Berger does discuss a specific-causation decision by Judge Jack Weinstein, in In re Zyprexa, 2009 WL 1357236 (E.D.N.Y. [read post]
14 Oct 2010, 10:11 am by Bexis
Tires Products Liability Litigation, 333 F.3d 763 (7th Cir. 2003), the first appellate case to apply collateral estoppel in this fashion.Although the class representative in a class action has about as much control of what’s going on as does a wooden lady mounted on the prow of a ship, the nominal plaintiff is important to collateral estoppel. [read post]
28 Oct 2011, 7:00 am by Bexis
  This common-sense notion, that a warning that’s not read cannot be causal, has been bedrock law in prescription medical product liability litigation for decades: Alabama In re Trasylol Products Liability Litigation, 2011 WL 2117257, at *5 (S.D.Fla. [read post]
14 Feb 2009, 11:56 am
Gibson Dunn already is seeing a surge in labor and employment, consumer fraud, and products liability litigation. [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]